Hexagon Capital Partners’s Clover Health Investments CLOV Stock Holding History

Hexagon Capital Partners’s Portfolio CLOV Stock Details CLOV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-2,000	Closed	-$7.18K	–	370
2025 Q1	$7.18K	Sell	2,000 -600	-23%	-$2.41K	﹤0.01%	1067
2024 Q4	$8.19K	Buy	2,600 +600	+30%	+$2.14K	﹤0.01%	1071
2024 Q3	$5.64K	Hold	2,000	–	–	﹤0.01%	1035
2024 Q2	$2.46K	Hold	2,000	–	–	﹤0.01%	1133
2024 Q1	$1.59K	Hold	2,000	–	–	﹤0.01%	1204
2023 Q4	$1.91K	Hold	2,000	–	–	﹤0.01%	1138
2023 Q3	$2.16K	Hold	2,000	–	–	﹤0.01%	1054
2023 Q2	$1.79K	Hold	2,000	–	–	﹤0.01%	1096
2023 Q1	$1.69K	Sell	2,000 -1	-0%	-$1	﹤0.01%	1103
2022 Q4	$1.86K	Hold	2,001	–	–	﹤0.01%	1098
2022 Q3	$3K	Hold	2,001	–	–	﹤0.01%	1014
2022 Q2	$4K	Hold	2,001	–	–	﹤0.01%	836
2022 Q1	$7K	Buy	+2,001	New	+$5.8K	﹤0.01%	658
2021 Q2	–	Sell	-23	Closed	–	–	818
2021 Q1	$0	Buy	+23	New	+$260	﹤0.01%	742

Other funds holding CLOV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Hexagon Capital Partners's CLOV Position: Q2 2025 in Review

Hexagon Capital Partners sold out of Clover Health Investments (CLOV) in Q2 2025, closing a stake of 2,000 shares — an estimated $7.18K sold.

Hexagon Capital Partners first reported a position in CLOV in Q1 2021 and held it in 14 quarters. The position peaked at $8.19K in Q4 2024. 200 funds tracked by Wall St. Rank hold CLOV as of Q2 2025.

Hexagon Capital Partners reported no remaining Clover Health Investments position as of Q2 2025 after selling out during the quarter.
Hexagon Capital Partners sold 2,000 Clover Health Investments shares in Q2 2025, an estimated $7.18K.
Hexagon Capital Partners first reported a position in Clover Health Investments in Q1 2021 and held it in 14 quarters.
Hexagon Capital Partners's Clover Health Investments position peaked at $8.19K in Q4 2024.
200 funds tracked by Wall St. Rank held Clover Health Investments as of Q2 2025.

Based on Hexagon Capital Partners's 13F filing for Q2 2025, filed 11 Aug 2025.